C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!

Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Prilenia receives positive EMA opinion on Orphan Drug Designation for pridopidine in ALS

Wednesday, June 30, 2021

Prilenia Therapeutics BV a clinical stage biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders received a positive opinion on European Orphan Drug Designation for pridopidine in Amyotrophic lat...

OnCusp Therapeutics Commences Operations to Advance Innovative Oncology Therapies

Wednesday, June 30, 2021

OnCusp Therapeutics a global biopharmaceutical company focused on translating cuttingedge research assets into innovative oncology therapeutics announced that it has officially commenced operations both in New York and Shanghai OnCusp successfully cl...

LFB Plasma Acquires ImmunoTek Bio Center in Greenacres and Establishes Flagship Office in Florida

Tuesday, June 29, 2021

LFB Plasma announced today the acquisition of the ImmunoTek Bio Center located at Lake Worth Road Greenacres FL LFB Plasma is part of the LFB Group a global biopharmaceutical company that develops and provides plasmaderived and recombinant products...

Captivate Bio Signs Exclusive Distribution Agreement with PL BioScience Across North America

Tuesday, June 29, 2021

Captivate Bio a scientific cell culture solutions provider today announced it has signed an exclusive distribution agreement with PL BioScience GmbH a biotech company located in Aachen Germany to bring its portfolio of human platelet lysate to market...

Nucleai and Merck KGaA Darmstadt, Germany Launch Translational Medicine Collaboration Utilizing Nucleai’s AI-Powered Biomarker Platform

Saturday, June 26, 2021

Nucleai a precision medicine company using AIpowered image analysis technology to support novel pathologybased biomarker development and Merck KGaA Darmstadt Germany a leading science and technology company announced that they have entered into a lon...

Natera and BGI Genomics Announce Commercial Launch of the BGI/Natera Signatera Assay in China

Saturday, June 26, 2021

Natera Inc a pioneer and global leader in cellfree DNA cfDNA testing and BGI Genomics Co Ltd SZ one of the worlds leading genomics companies today announced the launch of the BGINatera Signatera Assay which is now available to biopharmaceutical custo...

Amgen Announces Approval Of Aimovig® (Erenumab) In Japan For The Suppression Of Onset Of Migraine Attacks In Adults

Thursday, June 24, 2021

Amgen announced that the Japanese Ministry of Health Labour and Welfare has granted marketing approval for Aimovig erenumab for the suppression of onset of migraine attacks in adults Aimovig is the first and only approved treatment in Japan to block...

Eisai and Biogen Inc. Announce U.S. FDA Grants Breakthough Therapy Designation for Lecanemab (BAN2401), An Anti-amyloid Beta Protofibril Antibody for the Treatment of Alzheimer’s Disease

Thursday, June 24, 2021

Eisai Co Ltd and Biogen Inc announced that the US Food and Drug Administration FDA has granted Breakthough Therapy designation for lecanemab BAN an investigational antiamyloid beta A protofibril antibody for the treatment of Alzheimers disease AD Bre...

Grace Science Receives U.S. FDA Orphan Drug Designation for GS-100, an AAV9 Gene Therapy for NGLY1 Deficiency

Wednesday, June 23, 2021

Grace Science LLC announced today that the US Food and Drug Administration FDA has granted orphan drug designation to GS an investigational AAV gene replacement therapy for the treatment of NGLY deficiency The FDA grants orphan drug designation to in...

Eurofins Discovery and ImmunoPrecise Announce Collaboration to Expand their Antibody Discovery Platform

Wednesday, June 23, 2021

IMMUNOPRECISE ANTIBODIES LTD the market leader in fullservice therapeutic discovery and development and Eurofins Discovery the leading provider of products and services to the drug discovery industry and a Eurofins Scientific ParisERF company announc...

Latest Issue
Get instant
access to our latest e-book
Saving Money, Saving Time In Pharma Operations